Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Jan 10, 2012	ROBERTS WILLIAM VP Regulatory Development and Trans History: 288	VP Regulatory Development and	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	6,891	$73.92	72,148
Jan 10, 2012	ROBERTS WILLIAM VP Regulatory Development and Trans History: 288	VP Regulatory Development and	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	6,881	$73.92	90,301
Jan 10, 2012	ROBERTS WILLIAM VP Regulatory Development and Trans History: 288	VP Regulatory Development and	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	7,009	$73.92	83,292
Jan 10, 2012	Terifay Robert J SVP Commercial Trans History: 172	SVP Commercial	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	5,233	$73.92	22,267
Jan 10, 2012	Terifay Robert J SVP Commercial Trans History: 172	SVP Commercial	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	4,651	$73.92	17,616
Jan 10, 2012	Terifay Robert J SVP Commercial Trans History: 172	SVP Commercial	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	554	$73.92	18,934
Jan 10, 2012	Terifay Robert J SVP Commercial Trans History: 172	SVP Commercial	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	543	$73.92	18,391
Dec 16, 2011	SCHLEIFER LEONARD S Director, President & CEO Trans History: 427	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	134,585	$52.03	209,407
Dec 16, 2011	SCHLEIFER LEONARD S Director, President & CEO Trans History: 427	Director, President & CEO	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	53,344	$52.03	156,063
Dec 14, 2011	GOLDBERG MURRAY A SVP Finance and Admin CFO Trea Trans History: 645	SVP Finance and Admin CFO Trea	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	4,622	$51.18	86,861

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media